• The 3rd National Festival and International Congress on Stem Cells and Regenerative Medicine
    Considerable advances in Stem Cells and Regenerative Medicine during the past decade, has created much hope for the treatment of chronic and incurable illnesses, such as various cancers, genetic illnesses, illnesses due to old age, and deterioration of tissues and organs.

  • Stem cell study brings scientists closer to understanding schistosomiasis
    Schistosomiasis currently affects more than 250 million people, mainly in Asia and Africa, and the WHO has estimated that it causes approximately 280,000 deaths per year.

  • Stem Cells Shows Promise For Repairing Torn Meniscus
    U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced it has demonstrated successful, in-human results in repairing meniscus tear after autologous stem cell therapy from adipose or fat tissue.

  • Heres Why CRISPR Stocks Have Gained as Much as 169percent in 2018
    Shares of the three companies pioneering medical applications of CRISPR gene-editing tools have soared higher through the first half of 2018.

  • New Gene-Editing Treatment Could Replace CRISPR Technology
    Researchers from Carnegie Mellon and Yale Universities have reportedly used gene-editing treatment to cure a genetic disorder in a mouse. It is the first time that such a method was used to treat the condition which is common during fetal development.